Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.

Robert J. Zeglin; Juliet L Fetteroll

doi:10.1177/0956462420937168

Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.

Robert J. Zeglin
, Juliet L Fetteroll

University of North Florida

Producción científica: Article › revisión exhaustiva

Resumen

Nearly all cases of cervical cancer are attributable to human papillomavirus (HPV), making it a significant women's health issue. Though there have been advances in the prevention of HPV via vaccination, significant barriers continue to suppress vaccination rates for girls.

Idioma original	American English
Páginas (desde-hasta)	976-981
Publicación	International Journal of Std & Aids
Volumen	31
N.º	10
DOI	https://doi.org/10.1177/0956462420937168
Estado	Published - jul 21 2020

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being
Gender equality

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Acceder al documento

10.1177/0956462420937168Licencia: Unspecified

Otros archivos y enlaces

Link to publication

Citar esto

@article{cd66d95bf7b74f23b0570e2034b77e06,

title = "Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.",

abstract = "Nearly all cases of cervical cancer are attributable to human papillomavirus (HPV), making it a significant women's health issue. Though there have been advances in the prevention of HPV via vaccination, significant barriers continue to suppress vaccination rates for girls.",

author = "Zeglin, \{Robert J.\} and Fetteroll, \{Juliet L\}",

year = "2020",

month = jul,

day = "21",

doi = "10.1177/0956462420937168",

language = "American English",

volume = "31",

pages = "976--981",

journal = "International Journal of Std \& Aids",

issn = "0956-4624",

publisher = "SAGE Publications, Inc.",

number = "10",

}

TY - JOUR

T1 - Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.

AU - Zeglin, Robert J.

AU - Fetteroll, Juliet L

PY - 2020/7/21

Y1 - 2020/7/21

N2 - Nearly all cases of cervical cancer are attributable to human papillomavirus (HPV), making it a significant women's health issue. Though there have been advances in the prevention of HPV via vaccination, significant barriers continue to suppress vaccination rates for girls.

AB - Nearly all cases of cervical cancer are attributable to human papillomavirus (HPV), making it a significant women's health issue. Though there have been advances in the prevention of HPV via vaccination, significant barriers continue to suppress vaccination rates for girls.

UR - https://europepmc.org/article/MED/32693737

U2 - 10.1177/0956462420937168

DO - 10.1177/0956462420937168

M3 - Article

SN - 0956-4624

VL - 31

SP - 976

EP - 981

JO - International Journal of Std & Aids

JF - International Journal of Std & Aids

IS - 10

ER -

Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.

Resumen

ODS de las Naciones Unidas

Disciplines

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto